Amneal Pharmaceuticals  logo
AMRXAmneal Pharmaceuticals
Trade AMRX now
Amneal Pharmaceuticals  primary media

About Amneal Pharmaceuticals

Amneal Pharmaceuticals (NASDAQ:AMRX) is a dynamic company specializing in the development, manufacture, and distribution of generic and specialty pharmaceutical products. Primarily focusing on a wide range of therapeutic areas, Amneal aims to provide high-quality medications that improve patient outcomes while striving to make healthcare more accessible. With a robust pipeline of products aimed at addressing complex diseases, the company is dedicated to innovation and expanding its portfolio to meet diverse healthcare needs. Amneal's objectives revolve around leveraging its R&D capabilities to fuel growth, fostering strategic partnerships, and ensuring environmental sustainability in its operations, aiming to create value for both patients and stakeholders.

What is AMRX known for?

Snapshot

Public US
Ownership
2002
Year founded
5113
Employees
New Jersey, United States
Head office
1 of 1
US Rank
Unknown
Sector
N/A
Sector rank
Loading Map...

Operations

All Locations
United States

Produtos e/ou serviços de Amneal Pharmaceuticals

  • Generic Pharmaceuticals: Producing high-quality generic pharmaceuticals across a variety of therapeutic areas.
  • Specialty Pharmaceuticals: Focused on developing unique treatments for complex diseases.
  • Biosimilars: Working on affordable alternatives to biologic drugs, emphasizing accessible healthcare.
  • Over-the-Counter Medications: Offering a range of over-the-counter products for various health needs.
  • Research and Development: Investing in innovative research to expand the pharmaceutical portfolio.
  • Partnerships and Collaborations: Engaging with other firms for development and distribution of pharmaceuticals.

equipe executiva do Amneal Pharmaceuticals

  • Mr. Chirag K. PatelCo-Founder, Co-CEO, President & Director
  • Mr. Chintu Patel R.Ph.Co-Founder, Co-CEO & Director
  • Mr. Anastasios G. KonidarisExecutive VP & CFO
  • Mr. Jason B. Daly Esq.Executive VP, Chief Legal Officer & Corporate Secretary
  • Ms. Nikita ShahExecutive VP & Chief Human Resources Officer
  • Mr. Andrew S. BoyerExecutive VP and Chief Commercial Officer of Generics & Biosciences
  • Mr. Anthony DiMeoHead of Investor Relations
  • Mr. Gregory SgammatoSenior Vice President of Corporate Development
  • Mr. Pranav MehtaSenior VP of Strategic Sourcing & Supply Management
  • Dr. Sanjay Kumar Jain Ph.D.Chief Quality Officer

Connect with us

Disclaimer

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.